PAVmed Net Debt from 2010 to 2024

PAVMZ Stock

USD 0.01 0.0001 0.66%

PAVmed Series Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2024. Net Debt is the total debt of PAVmed Series Z minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2015-03-31

Previous Quarter

24.5 M

Current Value

34.2 M

Quarterly Volatility

21.3 M

Yuan Drop

Covid

Check PAVmed Series financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PAVmed Series' main balance sheet or income statement drivers, such as Interest Expense of 559.5 K, Selling General Administrative of 32.5 M or Other Operating Expenses of 74.8 M, as well as many indicators such as Price To Sales Ratio of 11.54, Dividend Yield of 3.0E-4 or Days Sales Outstanding of 14.05. PAVmed financial statements analysis is a perfect complement when working with PAVmed Series Valuation or Volatility modules.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Latest PAVmed Series' Net Debt Growth Pattern

Below is the plot of the Net Debt of PAVmed Series Z over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. PAVmed Series' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PAVmed Series' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Net Debt

Timeline

PAVmed Net Debt Regression Statistics

	Arithmetic Mean	(1,771,542)
	Coefficient Of Variation	(1,326)
	Mean Deviation	10,312,850
	Median	(839,077)
	Standard Deviation	23,488,235
	Sample Variance	551.7T
	Range	107.8M
	R-Value	0.06
	Mean Square Error	592.2T
	R-Squared	0
	Significance	0.84
	Slope	298,074
	Total Sum of Squares	7723.8T

PAVmed Net Debt History

	2024	30.5 M
	2023	29.1 M
	2022	-3.1 M
	2021	-77.3 M
	2020	-2.3 M
	2019	1.9 M
	2018	-319.1 K

Other Fundumenentals of PAVmed Series Z

Net Debt To E B I T D A

PAVmed Series Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Capital Surpluse	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Property Plant Equipment	Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Short Long Term Debt	Capital Stock	Short Term Debt	Short Term Investments	Net Tangible Assets	Current Deferred Revenue	Net Receivables	Good Will	Intangible Assets
Total Assets		0.3	-0.58	-0.66	0.75	0.45	1.0	0.79	0.78	0.7	-0.66	-0.16	0.81	0.61	0.82	0.67	0.82	0.81	0.21	0.78	0.87	0.21	-0.43
Total Stockholder Equity	0.3		-0.94	0.51	-0.28	-0.7	0.38	0.47	0.1	-0.26	0.18	0.72	0.79	0.93	-0.23	-0.44	-0.23	-0.26	-0.74	-0.29	0.38	-0.74	0.7
Net Debt	-0.58	-0.94		-0.22	0.0	0.45	-0.65	-0.6	-0.31	0.01	0.04	-0.52	-0.92	-1.0	-0.08	0.17	-0.09	-0.04	0.52	-0.03	-0.65	0.52	-0.45
Retained Earnings	-0.66	0.51	-0.22		-0.92	-0.97	-0.6	-0.35	-0.66	-0.86	0.76	0.74	-0.11	0.18	-0.91	-0.96	-0.9	-0.92	-0.77	-0.91	-0.5	-0.77	0.92
Capital Surpluse	0.75	-0.28	0.0	-0.92		0.86	0.72	0.57	0.88	0.96	-0.91	-0.59	0.34	0.02	0.84	0.95	0.84	0.82	0.58	0.8	0.57	0.58	-0.72
Total Liab	0.45	-0.7	0.45	-0.97	0.86		0.39	0.2	0.56	0.8	-0.72	-0.8	-0.12	-0.42	0.78	0.93	0.78	0.81	0.8	0.8	0.27	0.8	-0.95
Total Current Assets	1.0	0.38	-0.65	-0.6	0.72	0.39		0.79	0.78	0.67	-0.64	-0.13	0.85	0.67	0.77	0.62	0.77	0.75	0.15	0.73	0.9	0.15	-0.35
Common Stock	0.79	0.47	-0.6	-0.35	0.57	0.2	0.79		0.8	0.57	-0.61	0.25	0.85	0.6	0.48	0.45	0.48	0.52	-0.26	0.38	0.47	-0.26	-0.16
Accounts Payable	0.78	0.1	-0.31	-0.66	0.88	0.56	0.78	0.8		0.86	-0.92	-0.21	0.61	0.31	0.64	0.73	0.64	0.62	0.19	0.56	0.57	0.19	-0.39
Property Plant Equipment	0.7	-0.26	0.01	-0.86	0.96	0.8	0.67	0.57	0.86		-0.88	-0.54	0.32	0.01	0.78	0.93	0.78	0.76	0.54	0.74	0.53	0.54	-0.67
Long Term Debt	-0.66	0.18	0.04	0.76	-0.91	-0.72	-0.64	-0.61	-0.92	-0.88		0.41	-0.37	-0.05	-0.67	-0.8	-0.67	-0.65	-0.41	-0.63	-0.46	-0.41	0.54
Long Term Debt Total	-0.16	0.72	-0.52	0.74	-0.59	-0.8	-0.13	0.25	-0.21	-0.54	0.41		0.35	0.48	-0.48	-0.63	-0.48	-0.49	-0.8	-0.55	-0.25	-0.8	0.74
Net Invested Capital	0.81	0.79	-0.92	-0.11	0.34	-0.12	0.85	0.85	0.61	0.32	-0.37	0.35		0.92	0.36	0.17	0.36	0.34	-0.36	0.28	0.72	-0.36	0.15
Net Working Capital	0.61	0.93	-1.0	0.18	0.02	-0.42	0.67	0.6	0.31	0.01	-0.05	0.48	0.92		0.11	-0.15	0.11	0.07	-0.5	0.06	0.68	-0.5	0.42
Short Long Term Debt	0.82	-0.23	-0.08	-0.91	0.84	0.78	0.77	0.48	0.64	0.78	-0.67	-0.48	0.36	0.11		0.9	1.0	0.97	0.68	0.99	0.68	0.68	-0.78
Capital Stock	0.67	-0.44	0.17	-0.96	0.95	0.93	0.62	0.45	0.73	0.93	-0.8	-0.63	0.17	-0.15	0.9		0.9	0.88	0.71	0.87	0.46	0.71	-0.85
Short Term Debt	0.82	-0.23	-0.09	-0.9	0.84	0.78	0.77	0.48	0.64	0.78	-0.67	-0.48	0.36	0.11	1.0	0.9		0.97	0.68	0.99	0.68	0.68	-0.78
Short Term Investments	0.81	-0.26	-0.04	-0.92	0.82	0.81	0.75	0.52	0.62	0.76	-0.65	-0.49	0.34	0.07	0.97	0.88	0.97		0.6	0.97	0.6	0.6	-0.86
Net Tangible Assets	0.21	-0.74	0.52	-0.77	0.58	0.8	0.15	-0.26	0.19	0.54	-0.41	-0.8	-0.36	-0.5	0.68	0.71	0.68	0.6		0.73	0.27	1.0	-0.75
Current Deferred Revenue	0.78	-0.29	-0.03	-0.91	0.8	0.8	0.73	0.38	0.56	0.74	-0.63	-0.55	0.28	0.06	0.99	0.87	0.99	0.97	0.73		0.68	0.73	-0.82
Net Receivables	0.87	0.38	-0.65	-0.5	0.57	0.27	0.9	0.47	0.57	0.53	-0.46	-0.25	0.72	0.68	0.68	0.46	0.68	0.6	0.27	0.68		0.27	-0.22
Good Will	0.21	-0.74	0.52	-0.77	0.58	0.8	0.15	-0.26	0.19	0.54	-0.41	-0.8	-0.36	-0.5	0.68	0.71	0.68	0.6	1.0	0.73	0.27		-0.75
Intangible Assets	-0.43	0.7	-0.45	0.92	-0.72	-0.95	-0.35	-0.16	-0.39	-0.67	0.54	0.74	0.15	0.42	-0.78	-0.85	-0.78	-0.86	-0.75	-0.82	-0.22	-0.75

Click cells to compare fundamentals

About PAVmed Series Financial Statements

PAVmed Series investors use historical fundamental indicators, such as PAVmed Series' Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in PAVmed Series. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	29.1 M	30.5 M
Net Debt To EBITDA	(0.38)	(0.36)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for PAVmed Stock Analysis

When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PAVmed Net Debt from 2010 to 2024

Latest PAVmed Series' Net Debt Growth Pattern

PAVmed Net Debt Regression Statistics

PAVmed Net Debt History

Other Fundumenentals of PAVmed Series Z

PAVmed Series Net Debt component correlations

About PAVmed Series Financial Statements

Also Currently Popular

Additional Tools for PAVmed Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY